Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx

/PRNewswire/ -- Qiming Venture Partners' portfolio company Abbisko (SEHK:2256), a clinical-stage biopharmaceutical company, listed on the main board of the...

Related Keywords

Shanghai ,China ,Hong Kong ,Shenzhen ,Guangdong ,Suzhou ,Jiangsu ,Boston ,Massachusetts ,United States ,Beijing ,Qiming ,Sichuan ,Xiaomi ,Fujian ,Sanyou ,Anhui ,Venus Medtech ,Cansino Biologics ,Gan Lee Pharmaceuticals ,Wedoctor Group ,Zai Lab ,Hong Kong Stock Exchange On ,Shanghai Stock Exchange ,Nasdaq ,Astrazeneca ,Shenzhen Stock Exchange ,Horizon Health ,Venture Partner ,Hong Kong Stock Exchange ,Venture Partners ,Managing Partner ,Qiming Venture Partners ,San Francisco Bay ,Gretai Securities Market ,Lee Pharmaceuticals ,Sanyou Medical ,New Horizon Health ,Berry Genomics ,